Featured

A Drug “sur-mesures”: Immunotherapy and the Rise of Personalized Medicine



Published
8:30AM PT, 5:30PM GMT - Opening Remarks

Frédéric Jung - Consul General of France in San Francisco

Nevan Krogan - Director of Quantitative Biosciences Institute

Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US



8:45AM PT, 5:45PM GMT - A Drug “Sur-mesures”: immunotherapy and the rise of personalized medicine

Immunotherapy is becoming a more and more mature approach for curing a wide range of ailments, from cancers to auto-immune diseases. It is usually based on highly personalized treatments for specific markers and targets. In this panel, specialists will explain how its rise comes from the successful and powerful combination of several disciplines: immunology, statistical analysis, and computer science to name a few.

Moderator: Jean-Baptiste Bordes - Attaché for Science and Technology, Science and Technology Department of the French Embassy in the US

Aude Chapuis - Associate Professor, Program in Immunology - Clinical Research Division; John C. and Karyl Kay Hughes Endowed Chair, Fred Hutchinson

Julien Mamet - Founder, CSO and Board Member at Adynxx, Inc
Category
Health
Be the first to comment